Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole Augmentation in Treatment-Resistant Depression
NCT00174876Phase 2Completed
- Sponsor
- Upstate Medical University
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aripiprazole in major depressive disorder (MDD), sponsored by Upstate Medical University. Started Jul 2004; status: completed.
02
Drugs
aripiprazole
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00174876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174876.